Clinical Trials Directory

Trials / Conditions / Kidney Transplant Recipient

Kidney Transplant Recipient

13 registered clinical trials studyying Kidney Transplant Recipient4 currently recruiting.

StatusTrialSponsorPhase
RecruitingVascular Complications After Kidney Transplantation
NCT07531966
University of Aarhus
Not Yet RecruitingRenal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission
NCT07488481
University Health Network, TorontoEARLY_Phase 1
Not Yet RecruitingSemaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
NCT06913023
University Health Network, TorontoPhase 2 / Phase 3
Not Yet RecruitingOutcomes of a Pre-operative Exercise Programme for Live Donor and Recipient Kidney Transplant Patients
NCT06858098
University of ManchesterN/A
CompletedInvestigation of the Effects of Quadratus Lumborum Block Applied to Patients in Kidney Transplant Surgery
NCT06011850
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
CompletedSubcutaneous Abatacept in Renal Transplant Recipients
NCT05975450
Idelberto BadellPhase 1
TerminatedJanssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
NCT05220397
Mark StegallPhase 3
CompletedTelevideo Exercise and Nutrition Program for Kidney Transplant Recipients
NCT03697317
University of Kansas Medical CenterN/A
CompletedClinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severit
NCT01753505
Yonsei UniversityN/A
CompletedIsoniazid (INH) Treatment Based on ELISPOT Assay
NCT01087190
Asan Medical CenterN/A
CompletedChronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Rec
NCT01093703
Mayo ClinicN/A
CompletedRituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
NCT00307125
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedPharmacokinetics of Mmf and Valganciclovir
NCT00189150
University of MichiganPhase 4